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Arterial thrombus forms from the capture and accumulation of circulating 
platelets on a stenosis. As the thrombus grows, the lumen becomes further stenotic 
producing very high shear rates as the blood velocities increase through the narrowed 
cross-section. This study explores the molecular binding conditions that may occur under 
these pathologic shear conditions where circulating platelets must adhere quickly and 
with strong bonds.   
Platelets binding in an arterial stenosis of >75% are subject to drag forces 
exceeding 10,000 pN.  This force can be balanced by 100 simultaneous GPIb-vWFA1 
bonds of 100 pN each. The number and density of GPIb on platelets is sufficiently high; 
however, platelet capture under high shear would require the density of A1 receptors to 
be increased to over 416 per square micron. A computational model is used to determine 
platelet capture as a function of shear rate, surface receptor density, surface contact and 
kinetic binding rate.  A1 density could be increased by a combination of vWF events of: 
i) plasma vWF attach to the thrombus surface and elongate under shear; ii) the elongated 
vWF strands create a net with 3-D pockets; and iii) additional vWF is released from 
mural platelets by activation under shear. With all three events, A1 density matches the 
existing high GPIbα densities to provide sufficient multivalency for capture at 100,000 s-
1 with greater than 170 bonds per platelet.  If the on-rate is greater than 108 M-1s-1, then a 
platelet could be captured within 15 microseconds, the amount of time available to form 
bonds before the platelet is swept away. This mechanism of platelet capture allows for 





 Blood can be separated into two separate parts: plasma and blood cells.  The 
plasma consists primarily of water but also carries proteins (such as von Willebrand 
factor and fibrinogen), albumin, electrolytes and dissolved nutrients, to name a few.  The 
cells that are suspended in the plasma fluid are primarily red blood cells, platelets and 
leukocytes.  Nearly all of the cells in the blood are red blood cells; this plays an important 
role in how the different cells distribute themselves throughout the flowing blood.  Red 
blood cells are, roughly, 7-micron biconcave disc-shaped cells.  Platelets can take a 
variety of shapes and sizes, but measure only, roughly, 3 microns in diameter.  
Leukocytes measure larger than red blood cells at, roughly, 10 microns in diameter.  The 
size and population of red blood cells causes the smaller and sparser platelets to be 




 Blood flow, in bulk, is modeled as a typical fluid using the laws of Navier-Stokes; 
however, its particulate nature can make this approximation inaccurate.  In this study, 
blood flow will be considered on a single platelet scale near the wall.  On such a small 
scale the effect of the particulate nature of the fluid can be neglected and blood can be 




Figure 1: Depiction of hemodynamic properties of blood as considered in this study, 
where d is the distance from the wall, µ is the fluid viscosity, γ is the shear rate, and τ is 
the shear stress exerted by the fluid.  The platelet is drawn to scale at ~3 µm in diameter. 
 
Arterial Thrombosis 
 Thrombosis, evolutionarily, is a mechanism for hemostasis in the human body.  
When the body stands to lose blood, clots plug the leak through two mechanisms.  When 
blood shear rates are low, as with small cuts, a “red clot” is formed.  Low shear blood 
clotting has been well researched and uses platelet adhesion molecules such as 
fibrinogen, fibrin and fibronectin to capture red blood cells at the site of injury.  Less 
understood is the process by which the body forms high shear rate clots, or “white clot”.  
High shear thrombosis was likely intended to prevent massive bleeding in the case of a 
severe limb, for example.  The severed blood vessels constrict creating a narrowed 
section that induces high blood velocities that can initiate high shear thrombosis.  As 
humans begin to lead more sedentary lifestyles, the probability of a severed artery has 
declined and high shear thrombosis has become the source of myocardial infarction and 
stroke [Davies and Thomas, 1984].  As a leading cause of death worldwide, 
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atherosclerosis can become fatal when a high shear thrombus occludes an artery 
supplying the brain or heart.  Accordingly, there is great incentive to understand the 
processes of high shear thrombosis. 
 High shear thrombosis occurs in regions of vasculature where blood shear rates 
are very high (greater than 1,000 s-1) and is often due to a constriction in the vessel 
diameter due to atherosclerosis.  As the diameter of the blood vessel decreases, blood 
velocities increase according to the conservation of mass and create high shear rates.  In 
vitro studies of high shear thrombosis have shown that clots, or “thrombi”, tend to deposit 
throughout the regions of elevated shear [Ku and Flannery, 2007].  As thrombus 
continues to form on the walls of the constricted section, or “stenosis”, the effective 
diameter of the blood vessel continues to decrease, further increasing shear rate.  
Computational analysis has shown that shear rates in in vitro models can increase up to 
600,000 s-1 [Bark and Ku, 2010].  At such high shear rates near wall (5 µm) blood 
velocities can reach 3 m/s. 
 
Initial Platelet Capture 
 Platelets originate as cell fragments of megakaryocytes from the bone marrow, 
break off and enter the blood flow.  Platelets can vary in shape and size due to the way 
they are fragmented.  In size, platelets can vary from approximately 2 to 3 microns in 
diameter when modeled as a sphere [Paulus, 1975].  The shape of a platelet depends on 
the fluid conditions surrounding it.  As shear rate increases, platelets can change from 
discoid to spherical in shape [Maxwell et al, 2006]. 
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 Platelets can adhere to a number of adhesion molecules that allow a platelet to be 
captured to a blood vessel wall.  Collagen, which is exposed at sites of vessel wall 
endothelial cell injury, binds to glycoprotein IV, glycoprotein VI and integrin α2β1 on the 
platelet’s surface [Ruggeri and Mendolicchio, 2007].  Fibrin/Fibrinogen, which is present 
on the surface of low shear thrombus, binds to integrin αIIbβ3 [Ruggeri and Mendolicchio, 
2007].  von Willebrand factor, which is present in plasma and released from activated 
platelets, binds to the glycoprotein Ibα receptor on platelets and is the primary adhesion 
molecule for high shear platelet capture [Ruggeri and Mendolicchio, 2007].  Platelet 
glycoprotein Ibα binds to the A1 receptor on the von Willebrand factor protein. 
 Platelets travel through the vasculature in highest concentration near the vessel 
walls; this phenomenon is called platelet margination [Zhao, Kameneva and Antaki, 
2007].  As they pass by the vessel wall they usually do not come in contact with adhesion 
molecules.  At sites of vascular wall injury adhesion molecules such as collagen, von 
Willebrand factor (vWF), or fibrinogen could be present.  When a platelet from the flow 
comes in contact with one of these adhesion molecules, it has a certain amount of time to 
form a bond before the platelet has passed.  The bond cannot be formed if the forces 
imparted on the platelet exceed the strength of bond.  The strength of the bond, the force 
placed on the platelet and the allowable bond formation time will determine if the platelet 
will be captured from the flow.  In certain cases a cell can form a momentary bond with a 
wall-bound adhesion molecule before breaking free due to excessive force, causing the 
cell to adhere, break free and adhere repeatedly in a phenomenon called rolling [Yago et 
al, 2008]. 
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 A thin monolayer of platelet deposition occurs at the site of an injury by adhering 
to exposed adhesion molecules (most likely collagen).   
 
 
Figure 2: Depiction of the formation of a monolayer of thrombus in a progressive stenosis 
at high shear.  Platelets are represented as spheres for simplicity; platelet shape can vary 
and would likely be discoid shaped with pseudopod projections.  
 
Once this monolayer forms, inbound platelets are no longer binding to the endothelial 
wall (or exposed collagen) as it has been covered by platelets.  Instead another adhesion 
molecule (possibly vWF or fibrinogen) must bind platelets to the already-bound platelets.  
vWF and fibrinogen are present in plasma and can deposit on the surface of the growing 
thrombus.   
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Figure 3: Depiction of platelet deposition to existing thrombus in a progressive stenosis.  
Platelets are adhering to other platelets through an adhesion molecule (likely vWF). 
 
Simultaneously, bound platelets are activating (following a delay after initial capture) due 
to their bound state triggering an activation cascade and the shear force exerted by the 
moving fluid onto the platelets.  Activation causes a number of important processes.  The 
platelets flatten into a discoid shape and pseudopods extend from the membrane.  The 
integrin αIIbβ3 converts to an activated state allowing firm attachment of the platelet to 
the thrombus [Ruggeri and Mendolicchio, 2007].  Platelets release a number of signaling 
chemicals that cause nearby platelets to activate.  Platelets release a high concentration of 
adhesion molecules such as vWF.  With firm attachment and high concentrations of vWF 
and other adhesion molecules, the thrombus surface becomes a firm and sticky surface to 
capture inbound platelets.  This positive feedback loop (bound platelets inducing the 
binding of more platelets) could be the source of the rapid increases in thrombus growth, 




Prior In Vitro Experiments 
Prior in vtrvo experimentation conducted in our lab, which was the precedent for 
this work, demonstrates platelet adhesion under very high shear stresses [Ku and 
Flannery, 2007].  In these experiments whole porcine blood is flowed through a glass 
progressive stenosis model.  This can be seen in Figure 4. 
 
 
Figure 4: Blood flowing through glass progressive stenosis model.  Photo courtesy of 
Andrea Para. 
 
An optical microscope equipped with a video camera is used to capture footage of the 
blood flow at the stenosis.  The inside of the glass tubes are coated with collagen to 
promote initial platelet adhesion.  After mural thrombus has been created platelets begin 
to adhere more rapidly.  The thrombus growth continues to occlusion.  The camera 
footage is then analyzed using computational fluid dynamics. 
The computational fluid dynamics reveal that shear rates near occlusion can reach 
500,000 s-1 with platelet velocities on the order of 1 m/s [Bark and Ku, 2010].  While 
platelet adhesion cannot be verified at these shear rates, there is measurable thrombus 
growth at 100,000 s-1 and 1 m/s [Ku and Flannery, 2007].  These increasing shear rates 
and velocities are contrary to the rapid increases in the ability of platelets to bind to the 
thrombus surface. 
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As shear rate increases, along with shear stress and blood velocity, throughout 
thrombus growth platelets could experience increasing difficulty binding to the thrombus.  
Increased shear rates impart large forces on the binding platelet requiring that the bond 
formed between the platelet and the thrombus be very strong.  A reasonable platelet bond 
strength is 100 pN; at a shear rate of 100,000 s-1, a platelet experiences a force of ~10,000 
pN.  This would imply that much stronger undiscovered bonds or, more likely, 100 100-
pN bonds are necessary to capture a platelet.  Increased velocities give the platelet 
decreasing amounts of time to form bonds with the thrombus surface before they are 
swept away.  For a binding area the size of a platelet (~1 µm2), a blood velocity of 1 m/s 
would only allow ~5 µs of binding time before the platelet has left the binding area.  This 
would imply that the platelet would need to form ~100 bonds in ~5 µs.  This conclusion 
is profound considering the fast rate of bond formation and the lack or precedence for 
multiple simultaneous bonds in cell adhesion. 
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Specific Aims 
 The specific aim of this thesis is to outline a theoretical mechanism to describe 
high shear platelet capture.  The first part of the thesis seeks to quantify the bond force 
and binding time necessary to capture a platelet as a function of shear rate.  As shear rate 
increases near occlusion, the force imparted on the platelet and the time it has to bind 
increase and decrease, respectively.  In order to counteract the large unbinding forces one 
possible hypothesis is to invoke multivalent binding.  It will be necessary to determine if 
and how this is possible in the limited time allowed by the increasing platelet velocities.  
The second part of this thesis will be to develop a quantitative model for the binding 
reaction between the platelet and the thrombus surface.  This will require the 
modification of existing binding models to apply to the platelet capture reaction.  The last 
part of the thesis will be to describe and quantify the variables that contribute to fast-
forming multivalent adhesion between the platelet and the thrombus surface.  Finally, the 
proposed mechanism for high shear platelet capture will be analyzed, discussed and 
compared to current literature and physiological evidence. 
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MODEL FOR PLATELET CAPTURE 
Platelet Bonds 
 A thrombus begins often at a site of vascular injury where subendothelium is 
exposed.  Platelets can bind to subendothelium through a variety of adhesion molecules 
such as: fibrinogen/fibrin, fibronectin, collagen, vWF, laminin, vitronectin, fibulin and 
thrombospondin.  Once the injury site is covered with platelets (this layer is called the 
mural layer), platelets begin to bind to these bound platelets.  When the first layer of 
platelets binds to the subendothelium, this is referred to as initial adhesion.  When 
platelets begin binding to other platelets, this is called platelet aggregation.  This thesis 
will consider only platelet aggregation, which is the form of adhesion taking place as the 
thrombus grows to create high shear.  At high shear the primary adhesion molecules are 
vWF and fibrinogen [Ruggeri and Mendolicchio, 2007].  vWF plays a greater role in 
initial attachment and fibrinogen plays a greater role in stabilization of the thrombus 
[Ruggeri and Mendolicchio, 2007].  A depiction of the structure of a growing thrombus 




Figure 5: Depiction of thrombus structure and relevant adhesion molecules [Ruggeri and 
Mendolicchio, 2007]. 
 
This thesis is focused on the process of initial platelet capture at high shear; thus, vWF is 
the only adhesion molecule considered. 
 The bond created initially between a platelet and vWF is between the glycoprotein 
Ibα (GPIbα) molecule on the platelet surface and the A1 domain of the vWF protein.  
This bond has a strength between 80 and 120 pN [Yago et al, 2008]. 
 
Glycoprotein Ibα 
 GPIbα is a membrane bound receptor found on the surface of a platelet.  It is a 




Figure 6: Constituents and arrangement of the GPIb-V-IX platelet receptor [Arya et al, 
2005].  Relative heights of receptor components are shown approximately. 
 
GPIbα is the outermost, most accessible portion of the receptor and extends 45 nm from 
the surface of the platelet [Berndt et al, 1985].  For simplicity, the convention in this 
paper will be to refer to GPIbα as the “ligand” and vWF-A1 as the “receptor”; the vWF-
A1 receptor receives the GPIbα ligand on the inbound platelet. 
 Multiple GPIbα ligands exist on the surface of a platelet.  Berndt et al purified the 
GPIbα ligand from platelet membranes to determine how many ligands exist on the 
average platelet surface.  The results show that ~23,000 GPIbα ligands exist on a platelet 
membrane.  This plethora of ligands could suggest that multivalent binding between the 
platelet and vWF could exist. 
 
von Willebrand Factor 
 von Willebrand factor is a protein synthesized in endothelial cells and platelets.  
vWF is formed in the ER and Golgi apparatus of these cells, then secreted or stored in 
either Weibel-Palade bodies (endothelial cells) or α-granules (platelets) [Sadler, 2002].  
vWF is comprised of monomers that dimerize to form the repeating unit that builds the 
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protein [Fowler et al, 1985].  The relative dimensions of the dimer can be seen in Figure 
7 [Fowler et al, 1985]. 
 
 
Figure 7: Depiction of a vWF dimer and its relative dimensions [Fowler et al, 1985]. 
 
These dimers combine to form long vWF polymers as large as 15 µm in length [Fowler et 
al, 1985].   
 The A1 domain of the vWF molecule is located at the globular ends of each 
monomer.  These globular ends are depicted as white circles in Figure 7.  On each dimer, 
the repeating unit of the vWF protein, there are 2 A1 domains.  As the dimers assemble 
into multimers the A1 domains at each end of the dimers come together with a separation 








 vWF exists in two configurations: globular and elongated.  When vWF is released 
into the blood stream at low shear stress it assumes a folded tertiary structure [Sadler, 
2005].  Once this released vWF experiences high shear stress it unfolds into an elongated 
tertiary structure.  Elongated circulating vWF is cleaved into smaller vWF fragments by 
enzyme ADAMTS-13 [Zhang et al, 2009, Sadler, 2005].  This is the mechanism behind 
the heterogeneity of vWF multimer lengths.  As vWF has the ability to bind to collagen, 
platelets, Factor VIII and heparin, it can become immobilized on a thrombus or 
subendothelial matrix [Sadler, 1998].  When vWF is immobilized it can experience great 






Figure 9: vWF configurations as a function of shear rate [Schneider et al, 2007].  Bottom 
image depicts possible mechanism of vWF attachment to thrombus. 
 
 Thrombus vWF comes from three main sources: blood plasma, α-granules of 
platelets, and endothelial cells.  The vWF from endothelial cells contributes to the mural 
layer of thrombus as seen in Figure 5; thus, it is not relevant to platelet capture in 
aggregation.  Circulating plasma vWF comes in a variety of sizes as it has been cleaved 
by ADAMTS-13 and exists at a concentration of 0.01 mg/mL [Harrison and Cramer, 
1993].  Plasma vWF can be in its globular or elongated form and has the ability to 
become immobilized on any blood-contacting surface for which it has receptors.  vWF 
from platelet α-granules is usually released upon activation and exists at a concentration 
of 0.5 mg/mL [Harrison and Cramer, 1993].  Since there is a much higher concentration 
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of vWF inside platelets and since platelet activation and vWF release occur at the 
thrombus surface, platelets are the most relevant source of vWF to high shear platelet 
capture in aggregation. 
 vWF can self-associate [Savage, Sixma and Ruggeri, 2002].  This means that 
vWF can accumulate on the surface of a thrombus even after other vWF molecules 
consume platelet-binding ligands.  vWF can bind to other vWF molecules to form dense 
protein networks with a high affinity for platelets [Schneider et al, 2007]. 
 
 
Figure 10: Illustration of a possible configuration of vWF molecules on the surface of a 
thrombus, forming a dense protein network.  Dots represent A1 domains. 
 
Requirements for Platelet Capture 
 In order to arrest a platelet from the blood flow the platelet must be quickly and 
strongly associated to the thrombogenic surface.  “Quick” and “strong” depend primarily 
on the shear rate of the blood flow.   
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To capture a platelet, first, the bond between the platelet and the surface must 
strong enough to resist unbinding forces.  The primary unbinding force on an arrested 
platelet is from the blood flow. We will assume that blood flow near the wall can be 
approximated as Couette flow; this creates a linear velocity profile.  The viscosity of the 
fluid imposes a shear stress on the platelet.   
 
 
Figure 11: Illustration of forces on a platelet attached to a surface by a GPIbα-vWF-A1 
with dimensions. 
 
Maxwell et al have determined platelet shape to be a function of shear rate.  They find 
that at shear rates greater than 10,000 s-1 the majority of platelets assume a spherical 
shape [Maxwell et al, 2006].  Goldman et al have calculated Couette flow past an 
immobilized sphere to produce the following relationship: 
 
 Fplatelet = 6πµrhS, (1) 
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where µ is the viscosity of blood, r is the radius of the platelet, h is the distance from the 
wall to the center of the platelet, and S is the shear rate [Goldman et al, 1967].  The 
viscosity of blood near the wall is not precisely known [Ku, 1997].  Blood is a particulate 
fluid, which gives it non-Newtonian properties; viscosity decreases with increasing shear 
stress [Galdi et al, 2008].  However, in most arteries blood behaves as a Newtonian fluid 
[Ku, 1997].  We use a viscosity of whole blood, µ, of 4 mPa⋅s [Ku, 1997].  From the 
Maxwell et al study of platelet shape as a function of shear rate, we use a spherical 
platelet radius, r, of 1.5 µm [Maxwell et al, 2006].  The distance between the wall and the 
center of the platelet, h, is the platelet radius plus the length of the GPIbα ligand binding 
it to the wall, or 1.545 µm.  We examine the force on the platelet over a range of 
pathological shear rates.  For the lower end of the range we use 1,000 s-1 [Kroll et al 
1996].  For the upper end of the range we use 500,000 s-1 [Bark and Ku, 2010].  Forces 
over this range of shear rates can be seen below. 
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Platelet capture has been demonstrated at shear rates as high as 100,000 s-1 [Ku and 
Flannery, 2007].  Shear rates near occlusion have been shown to reach 500,000 s-1, but 
platelet capture has not been demonstrated at this shear rate [Bark and Ku, 2010].  The 
strength of a single GPIbα-vWF-A1 is 100 pN [Yago et al, 2008].  As can be seen in 
Figure 11, the drag force on a platelet exceeds 100 pN at ~600 s-1, continuing to ~17,000 
pN at 100,000 s-1. Considering that the GPIbα-vWF-A1 bond is the bond responsible for 
platelet capture at high shear, multiple GPIbα-vWF-A1 bonds must be created to resist 
the drag forces placed on the platelet above ~600 s-1.   
 
 
Figure 13: Illustration of increasing required number of bonds. 
 
A plot of the number of bonds that are required at a given shear rate can be derived from 




Figure 14: The number of bonds required to capture a platelet as a function of shear rate. 
 
According to Figure 13, ~170 bonds are required to capture a platelet at 100,000 s-1.  This 
is a large number of bonds to form quickly. 
 Secondly, in order for a platelet to be captured from the flow, the appropriate 
number of bonds must be formed before the platelet is swept away by the flow.  The 
velocity of a platelet near the vessel wall can approximated from the shear rate.  An 
inbound platelet will travel approximately 5 µm from the wall before it is captured.  At 
this distance the velocity of the platelet can be approximately using the following 
formula: 
 
 vp = Sd, (2) 
 
where vp is the velocity of the platelet, S is the shear rate and d is the distance from the 
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determine the amount of time the platelet has to bind to the thrombogenic surface by 
assuming a distance over which the platelet can bind.   
 
 
Figure 15: Illustration of a platelet flowing past a binding spot. 
 
Once the platelet flows past this binding spot, it can no longer bind.  This concept is con 
be written as follows: 
 
 tb = ls/vb, (3) 
 
where tb is the allowable binding time, ls is the length of the binding spot and vb is the 
platelet velocity.  We use a binding spot length, ls, of approximately one platelet diameter 
or 3µm.  By combining Equation (2) and Equation (3) and substituting known values (ls 
and d), we obtain the following relationship between binding time, tb, and shear rate, S: 
 
 tb = 1.5/S. (4) 
23	  
 
We plot the above equation to obtain Figure 15, demonstrating the allowable binding 
time at a given shear rate. 
 
 
Figure 16: Binding time as a function of shear rate. 
 
From Figure 15 we can see that at 100,000 s-1, a platelet has 15 microseconds to form a 
stable bond with the thrombus surface.  As mentioned earlier, ~170 bonds are required to 
arrest a platelet at 100,000 s-1; this means that in order for a platelet to be captured at this 
shear rate, 170 bonds must be formed in 15 microseconds.  This is a very fast binding 
rate; thus, we have developed a model to simulate this binding event and quantify the 
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Binding Model 
 A number of models exist for modeling the adhesion of a convecting cell to a 
surface.  While these models may accurately describe the scenario, they are difficult to 
use given what has been quantified about the bond in question.  The focus of these 
difficulties is the association and dissociation rate constants. 
 A valid model for platelet adhesion is the one proposed by Hammer and 
Lauffenburger in 1987.  This model considers a flowing cell with some density of surface 
ligands contacting a surface with some density of receptors over some known contact 
area.  This model is based on the following equation: 
 
 dNb/dt = kfNl0Na - krNb, (5) 
 
where Nb is the number of bonds per unit area, kf is the forward rate constant, Nl0 is the 
density of ligands on the cell, Na is the density of receptors on the surface and kr is the 
reverse rate constant [Hammer and Lauffenburger, 1987].  This equation is modified to 
include the effects of cell dimensions, contact area, contact time, ligand movement, bond 
interaction length and thermodynamics, resulting in the following equation: 
 
 dηb/dτ =θ[ηa - κηbexp(α/βRTηb)], (6) 
 dηa/dτ =θ[-ηa +κηbexp(α/βRTηb) + δ(1 - ηb)], (7) 
 
where ηb is the ratio of the bond density to the initial ligand density, τ is the ratio of time 
to contact time, θ is the bond formation rate, ηa is the ratio of the free ligand density to 
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the initial ligand density, κ is the dissociation rate, α is the bond breakage energy, β is the 
contact area, RT is the number of ligands and δ is the ligand accumulation rate [Hammer 
and Lauffenburger, 1987].  This model considers many important elements of platelet 
capture; however, this model cannot be used to compare values to literature as the on-rate 
constant on which it is based carries units of cm2/s while on-rates are typically reported in 
1/M⋅s.  On-rate constants are typically determined in an equilibrium reaction with ligands 
and receptors in solution; thus, molarity is important.  Without the ability to compare to 
literature values, we cannot determine the input value of the on-rate constant and, 
consequently, we cannot determine the solution to the equation.  If on-rate values could 
be measured in a way more consistent with this model and reported in cm2/s, then this 
model would be ideal for describing platelet capture. 
 Other improved models have been developed since Hammer and Lauffenberger’s 
model in 1987.  Hammer and King developed a model in 2001 that considers the 
geometric alignment of ligands on the cell and receptors on the surface [King and 
Hammer, 2001].  The model also considers the overlapping of the receptors and ligands.  
Another model by Krasik, Yee and Hammer in 2006 considers signal transduction upon 
bond formation, which can allow for the arrest of the cell through integrin activation 
[Krasik, Yee and Hamer, 2006].  Recently, Yago et al in 2007 consider the probability of 
a platelet bond forming based on collision frequency, area of contact and the densities of 
receptors and ligands [Yago et al, 2007].  Each of these studies, as well as a study by 
Mody and King in 2008, consider platelet bonds as springs that break free as a function 
of loading rate and other thermodynamic considerations using the Bell model [Mody and 
King, 2008, Bell, 1978].  The Bell model bond dissociation rate is based on the energy 
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being placed in the bond.   By assuming a fixed dissociation rate and bond strength, our 
model is simplified, though these values could be changed once the energy is known.  
Furthermore, Doggett et al in 2002 demonstrated that as force increases on the order of 
100 pN, dissociation rate increased on the order of 101 s-1 [Doggett et al, 2002].  At our 
greater forces we could expect the dissociation rate to be higher, but not by orders of 
magnitude.  We will instead assume the final bond dissociation force to be a constant 
~100 pN independent of loading rate as loading rate will tend to vary with fluid and 
surface conditions.  Each of the referenced models considers shear rates that are lower 
(maximum shear rates from 50 – 10,000 s-1) than the shear rates we are considering for 
this study.  These models predict behaviors at lower shear rates that could be relevant to 
high shear platelet capture.  Instead of considering the various phenomena that contribute 
to the platelet binding strength, we assume a fixed value for the bond strength of 
approximately 100 pN.  The bond strength could be varied in our model based on the 
loading rate, thermodynamic considerations, or other variables if they are known. 
 The most essential receptor-ligand binding equation is the equilibrium binding 
equation.  This equation addresses receptor-ligand binding in solution and is shown 
below: 
 
 dCb/dt = konClCr – koffCb, (8) 
 
where Cb is the concentration of receptor-ligand complexes, kon is the on-rate constant, Cl 
is the concentration of ligands, Cr is the concentration of receptors and koff is the off-rate 
constant [Trusky, Yuan and Katz, 2004].  Cl and Cr are the concentrations of ligands and 
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receptors at a time t.  Using initial receptor and ligand concentrations, Equation 8 can be 
rewritten as follows: 
 
 dCb/dt = kon (Cl0 - Cb)(Cr0 – Cb) – koffCb, (8) 
 
where Cl0 is the initial concentration of ligands and Cr0 is the initial concentration of 
receptors [Trusky, Yuan and Katz, 2004].  The inputs to this equation are receptor and 
ligand concentrations and on and off-rate constants.  On-rate and off-rate constants are 
available from previous studies.  Receptor and ligand concentrations, however, are not 
relevant to our binding scenario.  Receptors and ligands bound to surfaces and cell 
membranes are not in solution and, thus, are not easily described with a concentration.  In 
order to use this equation to more accurately describe platelet capture we must interpret 
bound receptors and ligands as concentrations. 
 A concentration of receptors or ligands can be determined from the number of 
receptors or ligands by assuming a volume as follows: 
 
 C = N/VNAV, (9) 
 
where C is the concentration, N is the number of ligands or receptors, V is the volume 
containing the receptors or ligands and NAV is Avogadro’s number [Trusky, Yuan and 
Katz, 2004].  A volume that best describes the platelet binding reaction must be 
determined. 
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 The binding reaction between a platelet and vWF-coated surface happens 
exclusively within the narrow space between the platelet and the surface.  A depiction of 
what this binding volume might look like can be seen in Figure 16. 
 
 
Figure 17: Depiction of binding volume for a platelet contacting a thrombogenic surface 
with approximately one third of its surface area. 
 
There are a number of receptors on the platelet surface that should not be considered in 
the binding volume as they are too far from the thrombogenic surface to take part in the 
reaction; therefore, it is necessary to define which receptors can be included in the 
binding volume; this will be handled explicitly in a later section.  Accordingly, the 
binding volume can be defined to include the surface area of the platelet that can be 
involved in the binding reaction; this area is shown in grey in Figure 16.  A third 
dimension is required to determine the binding volume.  We will assume the binding 
volume extends 45 nm, or the length of a GPIbα ligand, away from the surface of the 




 V = Ah = 4πr2Ph, (10) 
 
where A is the area of contact between the platelet and the thrombogenic surface, h is the 
height of a GPIbα ligand (45 nm), r is the platelet radius and P is the platelet contact 
percentage.  Instead of considering exact platelet contact areas, we will examine a few 
platelet contact percentages, or the percentage of platelet surface area that is within 
binding range of the surface.  Substituting Equations (9) and (10) into Equation (8) gives 
the following equation: 
 
 dNb/dt = kon(Nl0 - Nb )(Nr0 - Nb)/(VNAV) – koffNb. (10) 
 
 The numbers of receptors and ligands involved in the binding reaction depends on 
the density of receptors and ligands on the surfaces and the area over which they contact 
each other.  Accordingly, Equation 10 must be modified to more accurately describe this 
interaction.  The number of receptors can be written as follows: 
 
 N = φA = φP4πr2, (11) 
 
where N is the number of receptors or ligands and φ is the density of receptors or ligands 
on the platelet or thrombus surface.  Substituting Equation 11 into Equation 10 gives the 
following differential equation: 
 
 dNB/dt =(4πr2Pkon/hNAV)(φR – NB/4πr2P)(φL – NB/4πr2P) – koffNB. (12) 
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Equation 12 is the differential equation with which the platelet binding reaction will be 
modeled.  The number of bonds formed in a given amount of time can be determined by 
solving Equation 12 for various contact percentages, P, rate constants, kon and koff, 
receptor densities, φR, and ligand densities, φL.  Knowing the number of bonds formed in 
a given amount of time, we can determine if platelet capture is possible using Figure 13 
and Figure 15. 
 
Ligand Density 
 The density of GPIbα ligands on the surface of a platelet is a relatively fixed 
quantity. Though ligands are capable of diffusing in the cell membrane, this process is 
too slow for the capture events at very high shear.  Cell surface receptor mobility 
diffusion rates are on the order of 10-9 cm2/s [Schlessinger et al, 1976].  As binding 
occurs on the order of microseconds we can calculate how far a ligand could diffuse 
across the platelet surface in 10 microseconds.  With a diffusion rate of 10-9 cm2/s and a 
time of 10-5 s, a ligand could travel approximately 1 nm.  A nanometer of diffusion would 
not effect the distribution of ligands on the surface of the platelet significantly and thus 
we assume the ligand density to be fixed. A study by Dong et al in 1997, suggests that the 
GPIb-IX complex has restricted mobility to allow the ligand position to remain fixed for 
better geometric alignment with vWF [Dong et al, 1997]. 
 As GPIbα ligands are essentially fixed, the relative positioning of the vWF-A1 
domains governs the steric alignment of the GPIbα and vWF-A1 for bond formation.  
This is analogous to Velcro [U.S. Patent No. 2,717,437].  One surface of Velcro has 
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ordered, fixed, evenly spaced hooks (analogous to GPIbα ligands) while the other surface 
can be randomly ordered, is not fixed, dense (analogous to vWF).  The steric alignment 
of receptors and ligands thus becomes less important as the randomly located A1 
domains become denser.   
In a 1985 study Berndt et al radio labeled and counted the GPIbα molecules on 
the surface of a platelet.  Berndt et al examined data from 7 platelets to determine that 
these platelets carried ~23,000 GPIbα molecules on their surfaces.  This number varied 
by ~10%; as platelet size varies, this would suggest that the density of domains on a 
platelet would remain relatively constant.  Considering our earlier determined platelet 
dimensions (r = 1.5 µm), and assuming an even distribution of GPIbα ligands on the 
surface of the platelet, this gives a ligand density of ~800 GPIbα ligands per square 
micron.  This number will remain fixed throughout our simulations as the ligand density 
will likely remain unchanged for a particular platelet. 
 
Receptor Density 
 As the binding surface is created by vWF binding to the thrombus surface, the 
density of receptors varies with the amount of vWF on the surface and the availability of 
its A1 domains.  In order to determine the range of receptor densities we must consider 
the shape of vWF.  vWF on the thrombus surface can be in its globular or elongated 
form.  In its globular form, a 15 micron vWF protein can be modeled as a 1 micron 
diameter sphere [Schneider et al, 2007].  Elongated vWF can be modeled as a strand, 
which can then form many different contours.  We can determine the maximum vWF-A1 
receptor density by determining the maximum number of exposed A1 domains we can fit 
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in a given area.  Considering a 1 square micron area, we calculate the maximum number 
of A1 domains that can exist with vWF in its globular or elongated form. 
 Globular vWF approximately assumes the shape of a sphere.  This shape takes up 
a large amount of space with a low surface area.  Many of the A1 domains of the vWF 
protein in the sphere are inaccessible.  To determine how many A1 domains are available 
we assume the A1 domains of the 15 µm vWF protein that makes up the sphere are 
evenly distributed within its volume.  This is illustrated in Figure 17. 
 
 
Figure 18: Calculation of A1 domains accessible by platelet ligands. 
 
As vWF has 1 A1 domain every 120 nm, we can assume that a 15 µm long vWF protein 
has 125 A1 domains.  If we distribute these domains over the 5.24 x 10-19 m3 volume of 
the globular vWF protein, we obtain a volumetric density of 2.39 x 1020 A1 domains/m3.  
If we consider only the A1 domains that are accessible by the GPIbα molecule, then we 
can only consider the first 45 nm of volume from the surface of the sphere (Figure 17).  
This layer is ~1.29 x 10-19 m3 and, thus, contains ~31 A1 domains.  If we distribute these 
22 domains over the surface of the sphere, that gives a receptor density of ~10 domains 
per square micron.  As only one globular vWF protein can fit in a square micron, there is 
a single value of domain densities for globular vWF (or none).  In elongated form, 
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multiple vWF strands can occupy the square micron area simultaneously (Figure 18); 
thus, for elongated vWF we must consider a range of densities. 
  
 
Figure 19: Illustration of globular and elongated vWF and 1 square micron area. 
 
 In order to determine the maximum domain density for elongated vWF we must 
calculate the maximum number of vWF strands that can fit in a square micron.  If we 
assume that vWF proteins can lie directly next to each other without interference effects, 
we can calculate the close-packed density of elongated vWF from the dimensions given 
in Figure 8.  If we align vWF molecules as close together as possible (as depicted in 
Figure 19) we can fit one vWF protein every 4.5 nm. 
 
Figure 20: Maximum packing density calculation for elongated vWF 
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With one vWF strand every 4.5 nm, we can fit 222 strands widthwise in a square micron. 
Since there is one A1 domain every 120 nm lengthwise, there are 12 domains per strand 
in a micron of length.  This gives 2664 domains per square micron as the maximum 
domain density for elongated vWF.  This configuration is unlikely to form naturally and 
merely bounds a range of domain densities to test in the simulation.  The range for 
domain density of elongated vWF is thus 0 – 2664 domains per square micron. 
 To determine the effects of vWF concentrations released due to platelet 
activation, we calculated the domain density created by such a concentration.  vWF exists 
in plasma at a concentration of 0.01 milligrams per milliliter within an α-granule of a 
platelet at a concentration of 0.5 milligrams per milliliter.  This converts to 1x1013 and 
6x1014 vWFA1 domains per milliliter respectively.  These concentrations can be 
converted to planar vWFA1 densities yielding densities of 1 domain per square micron 
for plasma vWF concentrations and 50 domains per square micron for activated-platelet-
released vWF concentrations.  This suggests that activation is likely for receptor densities 
greater than 50 domains per square micron.  These values assume that the platelets 
release their entire α-granule contents and that all vWF present adheres to the aggregate.  
These densities can also increase since upstream vWF can accumulate on the aggregate 





Figure 21: Illustration of the effect of elongation and activation on receptor density and 
binding strength.  Shear rates listed are approximate.  vWF unfolds between 1,000 s-1 and 
6,000 s-1 [Schneider et al, 2007]. 
 
Contact Percentage 
 The percentage of the platelets surface area that comes in contact with the 
thrombogenic surface depends on the shape of the surface relative to the shape of the 
platelet.  The surface contour is determined by the platelets that make up the thrombus 
and the vWF (and other molecules) that lay on top of them.  We assume that the top-most 
layer of platelets creates the backbone of the thrombus contour and the vWF that lies on 
top of it creates the detailed features of the thrombus contour.  Since we assume that 
platelets are only binding to surface vWF at high shear, we can assume that the binding 
platelets that we are concerned with are only contact vWF covered surfaces.   
 Since the shape of vWF determines the contour of the platelet-binding surface we 
must consider its shape.  Each conformation of vWF creates a different area of contact 
with the binding platelet.  To determine the contact percentage that we use in the binding 
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simulation we must determine the contact area between a platelet and the various possible 
vWF contours. 
  Globular vWF most likely presents a concave binding surface to a binding 
platelet.  The extent of this concavity can vary with the shape of the vWF globule.  We 
model globular vWF as a 1 micron diameter sphere and, thus, for our model we use a 
single value for the platelet contact percentage of globular vWF.  To calculate this value 
we need to determine the contact are between to spheres (the platelet and the vWF) of 
different radii.  The area of contact is determined by calculating the area of the platelet 
that is within one GPIbα molecule length (45 nm) of the globular vWF.  This calculation 
is illustrated in Figure 21. 
 
 
Figure 22: Illustration of contact area calculation for globular vWF. 
 
In order to calculate x as seen in Figure 21, we use the following equation: 
 
 0.045 = Rplatelet - √(Rplatelet2 – (x/2)2) + RvWF - √(RvWF2 – (x/2)2), (13) 
 
where Rplatelet is the radius of the platelet and RvWF is the radius of the vWF globule.  We 
use a platelet radius of 1.5 µm and a vWF radius of 0.5 µm.  Solving the equation for x 
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gives a value of 0.362.  This gives a contact area of 0.1 µm2 or 0.7 % of the platelet 
surface area.  Thus, the platelet contact percentage for globular vWF is ~0.7%. 
 Elongated vWF can assume nearly any contour.  We assume that it is likely to 
conform to the surface to which it is bound.  The thrombus surface can achieve maximum 
platelet contact with a pocket.  The maximum contact percentage this pocket could have 
with the platelet is 50%.  If the pocket were any more curved, the platelet would not be 
able to enter.  Thus the maximum platelet contact percentage for elongated vWF is 50%. 
 We have also calculated the contact percentage created by a flat surface.  This is 
illustrated in Figure 22. 
 
 
Figure 23: Illustration of contact area calculation of flat vWF. 
 
In order to calculate x as seen in Figure 22, we use the following equation: 
 
 0.045 = Rplatelet - √(Rplatelet2 – (x/2)2). (14) 
 
Solving the equation for x gives a value of 0.792.  This gives a contact area of 0.4 µm2 or 
3 % of the platelet surface area.  Thus, the platelet contact percentage for flat vWF is 
~1%. 
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In our simulation we consider a few sample contact percentages: 0.7% (globular), 
1% (flat), 10%, 33% and 50%.  Figure 23 illustrates how surface contour can affect 
platelet contact percentage. 
 
 
Figure 24: Depictions (profile view) of a platelet contacting various contours of a vWF 
surface: (A) a 1 µm diameter sphere of globular vWF, (B) a flat elongated vWF and (C) a 
maximally concave elongated vWF (50% of platelet surface contacted).  Listed below 
each are the maximum contact area and the maximum number of domains that can be 
contacted (using a receptor density 2664 domains per square micron) 
 
Association Rate Constants 
The off-rate constant for a GPIbα-vWF-A1 bond has been calculated in a number 
of studies yielding a value of roughly 5 s-1 [Miura et al, 2000, Doggett et al, 2003, Kumar 
et al, 2003].  Investigations of the on-rate constant have produced varying results [Kumar 
et al, 2003].  In two different studies researchers used the dissociation concentration 
along with the previously mentioned off-rate measurements to estimate two different on-
rates: 103 and 105 M-1s-1 [Miura et al, 2000, Mody and King, 2008]. A common analogue 
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for platelet binding, leukocyte capture by selectins, suggests that the on-rate may be 
closer to 106 M-1s-1 [Mehta, Cummings and McEver, 1998].  The range of values for each 
of these kinetic rates is difficult to determine experimentally; thus, we vary the kinetic 
on-rate, kon, and determine what values can provide a plausible solution. In our 
simulations, we consider a range of on-rates from 103-1010, based on other biological 
bonds (Table 1). 
 






103 vWF/GPIb on-rate [Miura et al, 2000] 






[Mehta, Cummings and 
McEver, 1998, Nicholson et 
al, 1998] 
106 
Actin filament assembly 
[Salmon, McKeel and Hays, 
1984] Intra- cellular 
1010 Myosin/Actin [Marston, 1982] 
 
 
We assume that on-rate and off-rate do not vary with shear rate, as these are 
considered quasi-static equilibrium kinetic reactions.  In the case of the off-rate constant, 




Table 2: Summary of values used in simulations 
 
Variable Symbol Value 
GPIbα Density φL 800 µm-2 
vWF-A1 Density (Globular) φR 0-10 µm-2 
vWF-A1 Density (Elongated) φR 0-2664 µm-2 
Off-rate constant koff 5 M-1s-1 
On-rate constant kon 106-109 M-1s-1 
Platelet contact percentage P 0.4% (glob.), 
1% (flat), 10%, 33%, 50% (concave) 
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BINDING SIMULATION METHODS 
 In order to determine the effect of each variable on the ability for a platelet to be 
captured from a high shear flow, a simulation was developed using MATLAB 
(MathWorks, Natick, MA).  The output of the simulation is a plots showing the 
relationship between receptor density and the time it takes to form the required number of 
bonds for different shear rates, contact percentages and on-rates.  This is accomplished by 
iteratively solving Equation 12 over a range of inputs and extracting key data points.  The 
simulation used here uses Equation 10 for simplicity; Equation 12 can be used for a more 
straightforward, non-iterative calculation. 
 For a given set of inputs, Equation 10 is solved to give the number of bonds 
formed as a function of time.  This set of data is then analyzed to determine at what time 
point the appropriate number of bonds, for the given shear rate (Figure 13), is formed.  
This time point is then assigned to the receptor density used to solve Equation 10.  This 
process is iterated for the full range of shear rates, on-rates and receptor densities.  A 




Figure 25: Simulation flow chart. 
 
The simulation begins with 10 inputs: shear rate, length of the ligand, contact percentage, 
ligand density, range of receptor densities, first selected on-rate, second on-rate, third on-
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rate, fourth on-rate and off-rate.  Each iteration of the process depicted in Figure 20 uses 
a different receptor density from the 0 to 2663 domains per square micron.  The shear 
rate, S, is used to calculate the number of bonds necessary to capture the platelet, b, and 
the binding time, tb.  The contact percentage, P, is used to determine the area of contact 
between the platelets, A.  The ligand length, h, is then used with the contact area to 
determine the binding volume, V.  The ligand density, φL, and the contact area are used to 
determine the number of ligands involved in the reaction, Nl0.  The particular receptor 
density of a given iteration, φR, and the contact area are used to calculate the number of 
receptors used in that iteration, Nr0.  The off-rate, koff, the number of ligands, the number 
of receptors and the binding volume are then substituted into Equation 10.  Equation 10 is 
then solved over the time span (0 to tb) four different times using four different on-rates, 
kon1, kon2, kon3, kon4, chosen from Table 1.  The solutions, the number of bonds as a 
function of time, for each on-rate (4 solutions) are then analyzed to find the time point at 
which the appropriate number of bonds is reached.  These time points are assigned to 
their designated on-rate and receptor density in a matrix.  The process is then repeated for 
the next receptor density.  Once all iterations are complete, the resulting matrix is 
converted into plot of the time to form the necessary number of bonds versus receptor 
density.  Full detailed MATLAB code for this simulation can be found in Appendix A. 
 The simulation is run for a series of shear rates and contact percentages by hand 
(as opposed to another iterating loop).  After examining the resulting plots of each 
combination minimum receptor densities for capture are paired with their particular shear 
rate, on-rate and contact percentage.  These data are then presented in four 3-D plots 
(receptor density vs. shear rate vs. on-rate), one for each platelet contact percentage. 
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RESULTS 
Platelet Bonds as a Function of Time 
 The first result produced by the simulation is the number of bonds formed as a 
function of time for various shear rates and on-rates.  For each iteration the simulation 
creates a sample bonds-versus-time plot for a particular receptor density.  This particular 
receptor density can be set within the code before the simulation is run. 
 
 
Figure 26: The number of bonds formed as a function of time at a shear rate of 10,000 s-1, 
a platelet contact percentage of 10% and a receptor density of 500 domains/µm2. 
 
From Figure 25 we can see that as on-rate increases, bonds are formed more quickly.  As 
the number of available receptors and ligands are consumed, the rate of bond formation 
decreases.  At a platelet contact percentage of 10%, there are 2261 GPIbα ligands and 
1413 vWF-A1 receptors involved in the reaction.  This means the maximum number of 
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bonds that can form is 1416.  We expect that the number of bonds formed will 
asymptotically approach 1416 bonds.  We can see that over the time period plotted, an 
on-rate of 109 M-1s-1 approaches this value.  The model has predicted the binding 
reaction, as we would expect. 
 If we examine number of bonds versus time plots for other scenarios we can see 
what trends appear.  Increasing shear rate does not affect the binding rate; it simply 
determines how quickly the binding reaction must occur.  In the simulation shear rate is 
used to determine the time scales of the plots and the differential equation solver.  If we 
increase the platelet contact percentage, the binding rate should increase as more 
receptors and ligands are available for binding. 
 
 





Figure 28: Number of bonds formed versus time at 100,000 s-1, 50% platelet contact and 
500 domains/µm2. 
 
By increasing the platelet contact percentage by 5, we see create a 5-fold difference in the 
maximum number of bonds formed. 
 We can also affect the binding rate by altering the domain density.  By choosing 
the domain density created by globular vWF (10 domains/µm2) at a shear rate of 100,000 
s-1, we see the results demonstrated in Figure 28.  In order to isolate the effects of 
changing the domain density we will leave the platelet contact percentage at 10%, even 




Figure 29: Number of bonds versus time at 100,000 s-1, 10% platelet contact and 10 
domains/µm2. 
 






Figure 30: Number of bonds versus time at 100,000 s-1, 10% platelet contact and 1000 
domains/µm2. 
 
As with platelet contact percentage an increase in domain density sees an increase in 
binding rate.  This would suggest that the increase in platelet contact percentage and 
domain density created by the unfolding of vWF should create a large increase in binding 
rate. 
 By demonstrating the linear relationships in the results between platelet contact 
percentage, domain density and on-rate, we have verified the behavior of the model 
according to the relationships outlined in Equation 12.  The results from this aspect of the 
simulation are collected by the software loop described in Figure 24 and presented. 
 
Binding Time versus Domain Density 
 For a given shear rate and platelet contact percentage, it is useful to demonstrate 
the relationship between domain density and binding time.  Increasing domain densities 
49	  
can represent the change from globular to elongated vWF as well as increases in local 
vWF concentration.  The information from these plots can be used to determine what 
domain density, and what mechanisms, are necessary to capture a platelet at a given shear 
rate and platelet contact percentage. 
 By selecting the minimum time to form the required number of bonds from 
bonds-versus-time data at a particular shear rate, on-rate and platelet contact percentage, 
we can determine what domain density is required to capture a platelet in a certain 
amount of time.  This process is illustrated in Figure 30. 
 
 
Figure 31: Illustration of time points used to create binding time versus domain density 




In Figure 30, the required number of bonds at this shear rate (100,000 s-1) 170; thus, on-
rates of 109 and 108 can create 170 bonds in 1.5 and 14.5 microseconds, respectively, 
under these conditions.  Therefore, at 1500 domains/µm2 and 108 M-1s-1, the appropriate 
number of bonds is formed in 14.5 microseconds.  This data point is added to a matrix 
that, when completed, is plotted.  The process described in Figure 24 handles this process 
automatically.  The final plots for selected scenarios are presented below. 
 
 
Figure 32: The time required to form the required number of bonds (17) versus the 
receptor density at a shear rate of 10,000 s-1 and a platelet contact percentage of 10%. 
 
As we can see from Figure 31, the exponential decay seen in the bonds versus time plots 
is reflected in time versus domain density.  Decreases in domain density exponentially 
increase the amount of time it takes to form the necessary number of bonds.  In this case 
all four of the selected on-rates are sufficient to form the necessary number of bonds in 
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required 150 microseconds and capture the platelet.  The slower on-rates require greater 
densities of receptors to increase the reaction rate. 
 
 
Figure 33: Binding time versus domain density at 100,000 s-1 and 33% platelet contact. 
 
As the shear rate increases, the range of sufficient on-rates decreases.  At 100,000 s-1 106 
and 107 M-1s-1 are not sufficient to capture a platelet even though the contact percentage 
increased. 
 From these binding time versus domain density plots we can determine the 
minimum density required to capture a platelet and make conclusions regarding 
elongation, activation, shear rate and on-rate.  We select the minimum domain density 
from each binding time versus domain density plot (plots for all scenarios can be found in 
Appendix B) as is illustrated in Figure 33. 
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Figure 34: Binding time versus domain density at a shear rate of 100,000 s-1 and a contact 
percentage of 10%.  The horizontal line delineates the 15 microsecond binding time 
required to capture a platelet.  The vertical lines represent the domain densities required 
to achieve capture by that time point. 
 
Receptor Density vs. Shear Rate vs. On-rate vs. Contact Percentage 
By compiling these receptor densities for each combination of shear rate, on-rate 
and platelet contact percentage we can create the following plots, which allow us to 




Figure 35: Required domain densities for platelet capture for flat elongated vWF with 1% 
platelet contact. 
 
 Flat elongated vWF is insufficient to capture platelets at 100,000 s-1 and requires a 
very fast on-rate at 50,000 s-1.  An on-rate of 106 M-1s-1 is insufficient to capture a platelet 
at 10,000 s-1 with 1% platelet contact.  An on-rate of 107 M-1s-1 requires a very high 
concentration of vWF to bind to the thrombus surface and align appropriately.  As 
activation is required for domain densities greater that 50 domains/µm2, activation is 
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Figure 36: Required domain densities for platelet capture at 10% platelet contact. 
 
 At 10% platelet contact we see that platelet capture is not possible at 500,000 s-1 
and requires a very fast on-rate at 100,000 s-1.  We see that each of the four selected on-
rates is sufficient for platelet capture at some domain density.  An on-rate of 106 M-1s-1 
requires a very high domain density to capture a platelet with 10% platelet contact.  At 













+09	   1.00E+08	   1.00E+07	   1.00E+06	  


































On-­rate	  Constant	  [M-­1s-­1]	  
Concave	  Elongated	  vWF	  	  
(10%	  Platelet	  Contact)	  
55	  
 
Figure 37: Required domain densities for platelet capture at 33% platelet contact. 
 
 A platelet contact percentage of 33% is sufficient to capture a platelet at 500,000 
s-1 with a very fast on-rate and a very high domain density.  Activation is required for 
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Figure 38: Required domain densities for platelet capture at 50% platelet contact. 
 
 A platelet contact percentage of 50% is sufficient for platelet capture at with a fast 
on rate constant and a high domain density.  Activation is required for platelet capture at 
500,000 s-1 at 50% platelet contact.  All four on-rate constants are sufficient for platelet 
capture at 50% contact. 
 Globular vWF showed no data over this range of on-rates and shear rates; thus, 
platelet capture is not possible with globular vWF at the shear rates we have considered.  
With a maximum contact percentage of 0.07% and a maximum domain density of 10 
domains/µm2, globular vWF has a maximum of 1 A1 receptor available for binding.  This 
means that globular vWF can form, at most, one bond with a platelet.  Consequently, the 
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At this shear rate and domain density, an on-rate constant of 108 M-1s-1 is required to 
capture the platelet.  At a shear rate of ~1,000 s-1, globular vWF begins to unfold 
[Schneider et al, 2007].  This suggests that vWF unfolding occurs at the shear rate at 
which unfolded vWF becomes necessary. 
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DISCUSSION 
Thrombotic platelet accumulation is a critical mechanism in hemostasis that can 
also cause pathologic arterial occlusions [Ku, 1997].  For arterial stenoses, the local peak 
shear can reach 600,000 s-1 [Bark and Ku, 2010].  Thus, platelet capture and adhesion can 
occur at very high shear rates.  Our results use experimental data on GPIbα-vWF-A1 
bonding to describe one way of achieving platelet capture at these high shear rates 
through simultaneous activation release of vWF, elongation of the vWF molecule, and 
the formation of concave surfaces to match the high density of GPIbα already present on 
circulating platelets.  This study suggests a mechanism for high shear platelet capture that 
demonstrates the possible importance of vWF elongation and platelet activation to 
capture a platelet in high shear.  The vWF molecule shape change allows for very high 
densities of receptors to be exposed on the thrombus surface.  Platelet activation allows a 
high density of these molecules to assemble on the thrombus surface.  We have 
demonstrated the conditions that allow platelet capture under our model in terms of the 
amount and contour of vWF, the on-rate constant, and the shear rate.  
 
Summary of Results 
There are five major conclusions from this study.  First, our model suggests that 
multiple bonds are necessary to capture a platelet above ~600 s-1.  Multiple bonds have 
been suggested by previous work as a possible mechanism for overcoming large 
unbinding forces. Multiple simultaneous bonds have also been demonstrated in AFM 
experiments [Sulchek et al, 2005]. However, the simultaneous bonding of hundreds of 
bonds may be a unique mechanism to capture millions of circulating platelets under the 
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very high shear rates and drag forces for hemostasis.  We have analyzed the binding of a 
platelet to a surface of vWF, but we have not addressed how this surface adheres to the 
aggregate.  By the same force balance used in this study, the vWF must adhere to the 
aggregate with the appropriate number of bonds.  The number of bonds necessary to 
adhere the vWF surface and platelet to the aggregate is determined by the force of each 
bond and the drag force created by the platelet and vWF surface in flow. 
The second result of the model is that vWF unfolding is necessary for the 
exposure of multiple A1 domains within the footprint of a platelet.  A globular vWF 
would not be expected to have many A1 domains on its exterior surface, whereas an 
elongated strand of vWF could expose many more A1 domains.  Unfolding of vWF has 
been demonstrated at shears above 5,000 s-1 and would be consistent with the hypothesis 
that the increased domain densities created by elongated vWF could aid in platelet 
capture [Ruggeri, 2001, Ruggeri et al, 2006, Schneider et al, 2007]. 
A third consequence of the modeling indicates that overlapping strands of vWF 
can work in combination to provide more binding sites to capture a platelet at a shear rate 
of 50,000 s-1 with on-rates less than 108 M-1s-1.  At higher shear rates, hundreds of bonds 
are required, necessitating multiple strands of vWF within a small volume. In order to 
create the large density of bond receptors, a high concentration of vWF should remain 
near the surface of the aggregate.  These multiple strands would likely come from the 
local release of vWF from platelets on the thrombus surface that have been activated by 
lengthened exposure to very high shear stress.  The multiple strands could entangle to 
form a net of strands with a very high density of A1 domains.  Images of vWF under 
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shear suggest the surface of the thrombus could be coated with a net-like array of 
elongated vWF molecules [Schneider et al, 2007].   
Fourth, a concave contour with greater than 1% surface contact is necessary for 
platelet capture above 50,000 s-1 for on-rates less than 109 M-1s-1. Greater platelet contact 
allows many ligands and receptors to increase the binding rate between the platelet and 
the surface.  The concave contour could form pockets where platelets could create up to a 
thousand bonds between GPIbα and A1 receptors. As the three-dimensional vWF surface 
is not uniform, one would expect thrombus to form in patches and not in uniform layers, 
which has been observed in experiments of platelet aggregation at high shears [Ku and 
Flannery, 2007].   Thus, the increasing number of surface A1 receptors as shear increased 
would match the existing high density of platelet GPIbα ligands, leading to a Velcro-like 
immediate adhesion from hundreds of similarly spaced bonds.  However, since concave 
contours are spaced and often filled, one would expect that the probability of capture 
would decrease as shear rates become pathologically high. 
A fifth result establishes that the on-rate for GPIbα binding to vWF-A1 may be 
greater than 108 M-1s-1 under hemodynamic shear conditions above 10,000 s-1. Miura et al 
report an on-rate of ~1,000 M-1s-1 with bonding times of ~100 sec [Miura et al, 2000].  
Doggett indicate a bond time a thousand fold faster at ~ 0.1 s [Doggett et al, 2003].  
Mody et al calculate an on-rate of ~6 x 105 M-1s-1 [Miura et al, 2000, Mody and King, 
2008]. These values can differ by a factor of 600, probably due to 4 order of magnitude 
errors that can come from surface plasmon resonance measurements.  The on-rate 
constants required in our model are two orders of magnitude faster than other 
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intercellular bonds previously reported.  This could be due to the necessity for quick 
binding in hemostasis.   
 
vWF Unfolding 
We have demonstrated that vWF elongation is necessary for high shear platelet 
capture by our model.  By elongating vWF, vWF-A1 densities can increase by greater 
than 17 times and allow platelets to adhere with multiple bonds. The elongated vWF 
strands can cross link to form a net with 20 times the available A1 domains in a square 
micron.  The ability for vWF to create a variety of contours allows it to contact more of 
the platelet surface, accessing more GPIbα ligands.  A concave pocket on the surface of 
the thrombus allows up to 37 times more A1 domains for binding with platelet GPIbα.    
Conversely, globular vWF in plasma concentrations should not be able to capture 
a circulating platelet above 1,000 s-1 if only GPIbα-vWF-A1 binding is used.  Thus, other 
bonds such as GPIbα and fibrinogen may be more functional at the lower shear rates.  
Our study mechanically describes how vWF unfolding can affect the platelet 
binding process.   The use of quantitative modeling demonstrates the synergistic 
relationship between the vWFA1 domain density, the vWF contour and the on-rate to 
achieve platelet capture at shear rates up to 500,000 s-1.  The amounts of ligands and 
receptors necessary to capture a platelet in our model could provide a reason for the 





Activated-Platelet Release of vWF 
 In order to achieve the high domain densities provided by multiple strands of 
elongated vWF, platelet-activated release of vWF is necessary.  vWF concentrations 
released from platelets upon activation are 50 times higher than vWF concentrations in 
the plasma.  vWF released from platelets is also released locally.  This local release can 
allow a larger percentage of the vWF to come in contact with the thrombus surface.  
Previous studies have suggested local high concentrations of vWF may be essential for 
high shear platelet capture [Ruggeri and Mendolicchio, 2007]. 
 
Limitations 
There are some critical limitations and assumptions in this study.  First, Equation 
8 is based on equilibrium binding.  Equilibrium binding may not be an accurate 
description of the platelet-wall interaction.  Unfortunately, a more accurate description of 
non-equilibrium cell-surface binding is beyond the scope of this paper [Hammer and 
Lauffenberger, 1987].  A model that better describes a cell with membrane-bound ligands 
attaching to a surface of receptors would be a valuable future development for the 
understanding of this, and other, cell binding reactions.  Second, we have assumed that 
there exists no undiscovered 20,000 pN bond that could adhere a platelet to a thrombus 
without multivalency.  Third, we have assumed that on-rates, off-rates, and fluid 
velocities remain constant.  On-rates and off-rates can change with applied forces [Yago 
et al, 2007, Kumar et al, 2003].  This would allow for low on-rates at low shear that can 
increase with shear to accommodate for decreased binding time.  However, bonds with 
these characteristics, like catch bonds, typically release at very high shear forces.  
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Previous models have considered dissociation rates that change with force, based on the 
Bell model [Mody and King, 2008].  We have instead assumed an overall bond strength 
of 100 pN for simplicity.  While it is also likely that fluid velocities, and thus shear 
forces, will change with pulsatile flow or thrombus growth, we have considered steady 
flow for this analysis.  Lastly, we have assumed that the vWF surface responsible for 
capturing the platelet is stably bound to the aggregate.  To determine if the vWF surface 
can withstand the drag forces of the platelet(s) bound to it, a force balance must be 
performed between the bonds that bind the surface to the aggregate and the drag forces 
on the platelet(s) and vWF.  
A phenomenon often seen in platelet adhesion is rolling.  As platelets collide with 
the binding surface they form transient bonds that form and break causing the platelet to 
roll along the surface.  Our model does not consider rolling, but our model can be 
iteratively applied to each collision and describe the discrete events of the rolling process.  
As a platelet forms a bond with the surface and breaks free its velocity is slowed.  Now, 
with a lower velocity the platelet has a greater binding time and can form more bonds.  
This process can continue until the platelet is traveling slow enough to form the 
appropriate platelet bond strength with the surface.  Iteratively applying our model with 
new, slower, input velocities will simulate each individual binding attempt in a discrete 
fashion.  However, in vitro experiments have shown that platelets can accumulate at the 
upstream end of the stenosis.  This implies that there has been little if any rolling before 
capture.  Thrombosis that occurs on implanted mechanical devices such as artificial 
valves and stents would also require capture over very short distances and short time-
scales.  Platelets are able to adhere to edges of devices despite the short surface lengths 
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that cannot accommodate rolling across the surface.  A study by Ruggeri et al in 2006 
demonstrates that as shear rates increase and vWF plays a more predominant role, platelet 
adhesion switches from rolling to adherent attachment [Ruggeri, 2006].  The implications 
of platelet rolling do not effect the conclusions of this study.  Our model concentrates on 
the final interaction of the rolling process where the platelet creates a permanent 
attachment to the surface irrespective of prior rolling. 
  
Future Work 
A number of conclusions from this study can and should be verified 
experimentally.  Additionally, the conclusions of this study point to new areas of 
experimentation that can further elucidate the ideas set forth in this study. 
First, to determine the true range of achievable vWF-A1 densities, labeled vWF 
can be flowed over a surface and imaged.  By labeling the A1 domains on vWF with gold 
nanoparticles and releasing high concentrations into a blood flow over a layer of mural 
thrombus, the vWF can unfold and expose its domains.  Gluteraldehyde can then be used 
to fix the vWF in its elongated formation for imaging using SEM.   
Second, multiple bonds between a platelet and a thrombogenic surface can be 
demonstrated by laying down vWF, in a similar fashion as described above, and dragging 
a platelet fixed to an AFM tip over it.  As the platelet binds and unbinds, the force versus 
time data can demonstrate the number of unbinding events.  This is similar to a study by 
Sulchek et al in 2005 [Sulchek et al, 2005].   
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Third, platelets can be flowed over surfaces with known receptor densities to 
determine if capture is possible.  This would serve to validate Figures 34-37 while also 
narrowing the range of possible on-rate constants. 
Lastly, images of vWF conformations relative to bound platelets from an actual 
thrombus could verify and give further insight into the role of vWF contour in platelet 
capture. 
 
Implications of Results 
As hemostasis is life preserving, the need for platelet aggregation at very high 
shear rates is critical.  The progressive release, unfolding, and network conformation of 
vWF allows increasing platelet binding to vWFA1 under elevated shear without inducing 
the capture of platelets at low shear.  As life-preserving high shear platelet aggregation 
becomes less relevant in modern day life, high shear thrombosis may become a health 
risk.  Turning off this mechanism by inhibiting one of the steps described in this study, 
such as vWF unfolding, could allow for low shear hemostasis without the health risks of 
high shear arterial thrombosis. 
Knowledge and future evidence of the mechanism described in this paper could 
lead to drug developments that may help reduce the pathologic consequences of high 
shear thrombosis. Preventing vWF release from platelets or depleting their vWF supply 
may reduce local vWF concentrations and hinder high shear binding.  As a newer avenue 
of attack, interference with vWF unfolding may eliminate high shear adhesion altogether.  
Bleeding times from platelet adhesion with globular vWF would not be affected, but the 
high shear adhesion involved in arterial thrombosis could be prevented. 
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CONCLUSIONS 
This study demonstrates that activation coupled with vWF elongation can explain 
the very high shear platelet capture that occurs in severe stenoses.  Elongation and 
activation combine to form contoured surfaces coated in a high density of vWF-A1 
domains that capture platelets with large contact areas, high receptor-ligand 
concentrations and a fast on-rate constant.  Manipulation of this mechanism could lead to 
highly specific antithrombotic drugs for the prevention of occlusive arterial thrombosis. 
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APPENDIX A 




%inputs (time in microseconds) 
shearrate=1000; %force on cell in piconewtons (must be a 1 and zeros) 
bondstrength=100; %strength of bond in piconewtons 
vel=shearrate*1.5e-6; %cell velocity in m/s 
bindspot=3e-6; %distance cell must travel to be out of binding area in m 
lpsm=800; %ligands per square micron on cell surface 
rpsm=10; %receptors per square micron on binding surface 
rpsmmax=2664; %maximum per square micron density of receptors 
C=0.007; %platelet surface area contacting the surface [percent] 
sep=45; %length of ligand molecule [nm] 
kon1=1e6; %a possible binding association rate [M^-1*s^-1] 
kon2=1e7; %a possible binding association rate [M^-1*s^-1] 
kon3=1e8; %a possible binding association rate [M^-1*s^-1] 
kon4=1e9; %a possible binding association rate [M^-1*s^-1] 
koff=5; %the dissociation rate [s^-1] 
  

































%find number of bonds formed as a function of time 
for n=1:1:4; 
    kon=eval(['kon' num2str(n)]); 
    [t Y]=ode45(@hpsabvt,[0 assoctime],[0],[],r,l,V,kon,koff); 
    eval(['t_' num2str(n) '=t']); 
    eval(['y_' num2str(n) '=Y']); 
end 
  
%find 10 bond time points of simulations at 4 onrates and different 
%densities (for density plots) 
for n=b:b:rmax; 
    rs=n; 
    c=(n./b); 
    [t,y]=ode45(@hpsatvd,[0 atrun],[0 0 0 0],[],rs,l,V,kon1,kon2,kon3,kon4,koff); 
    [h1,i1]=min(abs(y(:,1)-b)); 
    [h1,i2]=min(abs(y(:,2)-b)); 
    [h1,i3]=min(abs(y(:,3)-b)); 
    [h1,i4]=min(abs(y(:,4)-b)); 
    tt1(c,1)=t(i1); 
    tt2(c,1)=t(i2); 
    tt3(c,1)=t(i3); 
    tt4(c,1)=t(i4); 
end 
  







































plot(t_4*10^6,y_4,':k','LineWidth',2);ylabel('Bonds [#]     ','fontsize',12,'fontweight','b'), xlabel('Time 
[microseconds]    ','fontsize',12,'fontweight','b') 
h=legend('kon=1e6','kon=1e7','kon=1e8','kon=1e9',4); 
set(h,'Interpreter','none') 




plot(r1,t1,':k','LineWidth',2);ylabel('Time to Form 170 Bonds [  \mus]     ','fontsize',12,'fontweight','b'), 














%semilogx(r4,t4smooth,'-.k','LineWidth',2);ylabel('Time to Form 170 Bond [  \mus]     
','fontsize',12,'fontweight','b'), xlabel('A1 Domain Density [#/ \mum^{2}]    ','fontsize',12,'fontweight','b') 
h=legend('kon=1e6','kon=1e7','kon=1e8','kon=1e9',4); 
set(h,'Interpreter','none') 




Binding Time vs. Domain Density Plots 
 
Figure 39: Binding time versus domain density at 10,000 s-1 and 1% platelet contact. 
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Figure 40: Binding time versus domain density at 10,000 s-1 and 10% platelet contact. 
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Figure 41: Binding time versus domain density at 10,000 s-1 and 33% platelet contact. 
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Figure 44: Binding time versus domain density at 50,000 s-1 and 10% platelet contact. 
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Figure 45: Binding time versus domain density at 50,000 s-1 and 33% platelet contact. 
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Figure 46: Binding time versus domain density at 50,000 s-1 and 50% platelet contact. 
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Figure 47: Binding time versus domain density at 100,000 s-1 and 1% platelet contact. 
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Figure 48: Binding time versus domain density at 100,000 s-1 and 10% platelet contact. 
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Figure 49: Binding time versus domain density at 100,000 s-1 and 33% platelet contact. 
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Figure 50: Binding time versus domain density at 100,000 s-1 and 50% platelet contact. 
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Figure 51: Binding time versus domain density at 500,000 s-1 and 33% platelet contact. 
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